Model for End-stage Liver Disease and Model for End-stage Liver Disease-Na Scores Predict Both Before-Listing and Wait-List Mortality

被引:9
|
作者
Yamashiki, N. [2 ]
Sugawara, Y. [1 ]
Tamura, S.
Kaneko, J.
Nojiri, K. [3 ]
Aoki, T.
Sakamoto, Y.
Hasegawa, K.
Koike, K. [2 ]
Kokudo, N.
机构
[1] Univ Tokyo, Artificial Organ & Transplantat Div, Dept Surg, Grad Sch Med,Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo 1138655, Japan
[3] Univ Tokyo, Organ Transplantat Serv, Grad Sch Med, Tokyo 1138655, Japan
关键词
TRANSPLANTATION; MELD;
D O I
10.1016/j.transproceed.2012.01.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Due to the organ shortage, many patients die without transplantation, even before completing an evaluation for candidacy. We analyzed outcomes after patient referral and factors associated with mortality both before and after listing for cadaveric donor liver transplantation. Methods. We analyzed 132 consecutive patients who were evaluated for candidacy for cadaveric donor liver transplantation between 2003 and 2010. Results. The study included 69 men and 63 women of median age 49 years (range, 1-65). Etiologies of diseases were acute hepatic failure (n = 19), liver cirrhosis due to hepatitis B or C (n = 36), primary biliary cirrhosis (n = 19), nonviral cirrhosis (n = 14), hepatocellular carcinoma (n = 13), or other causes (n = 31). After evaluation for candidacy, we listed 68 (52%), subjects whereas 24 (18%) died before listing. Factors affecting death before listing were the levels of albumin (P < .001), bilirubin (P < .001), sodium (P < .001), international normalized ratio (INR; P < .001), Model for End-stage Liver Disease (MELD) score (P < .001), MELD-Na score (P < .001), and Child-Pugh-Turcotte (CPT) score (P < .001). Based on multivariate Cox regression analysis, MELD score (hazard ratio [HR] 1.201, P = .017), MELD-Na score (HR 1.244, P = .014), CPT score (HR 1.468, P = .033), and INR (HR 0.491, P = .027) were independently associated with death before listing. Among 68 listed candidates, 11(16%) underwent transplantation, whereas 29 (43%) died without transplantation. Based on multivariate Cox regression analysis, MELD score (HR 1.102, P = .001), MELD-Na score (HR 1.128, P = .001), and CPT score (HR 1.282, P = .038) independently predicted wait-list mortality. All 11 patients who underwent cadaveric liver transplantation were alive at 29 months (range, 1-55) after transplantation. Conclusions. Patients with a higher MELD, higher MELD-Na, and higher CPT score at referral were at greater risk for death without transplantation, especially before listing. Evaluation for transplantation candidacy is a time-consuming process. Therefore, earlier referral is mandatory to achieve successful listing for transplantation.
引用
收藏
页码:389 / 392
页数:4
相关论文
共 50 条
  • [31] A prognostic model for patients with end-stage liver disease
    Cooper, GS
    Bellamy, P
    Dawson, NV
    Desbiens, N
    Fulkerson, WJ
    Goldman, L
    Quinn, LM
    Speroff, T
    Landefeld, CS
    GASTROENTEROLOGY, 1997, 113 (04) : 1278 - 1288
  • [33] Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis
    Choi, Pil Cho
    Kim, Hong Joo
    Choi, Woo Hyuk
    Park, Dong Il
    Park, Jung Ho
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    LIVER INTERNATIONAL, 2009, 29 (02) : 221 - 226
  • [34] Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease
    Sun, Fu-Rong
    Wang, Ying
    Wang, Bing-Yuan
    Tong, Jing
    Zhang, Dai
    Chang, Bing
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (01) : 50 - 54
  • [35] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40 (vol 77, pg 851, 2023)
    Tarlows, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 78 (04) : E84 - E84
  • [36] Survival on Waiting List for Liver Transplantation Before and After Introduction of the Model for End-stage Liver Disease Score
    Tenorio, A. L.
    Macedo, F. I. B.
    Miranda, L. E. C.
    Fernandes, J. L.
    da Silva, C. M.
    Neto, O. L. F.
    Lacerda, C. M.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 407 - 411
  • [37] Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?
    Amieva-Balmori, Mercedes
    Isabel Mejia-Loza, Scherezada Maria
    Ramos-Gonzalez, Roberto
    Zamarripa-Dorsey, Felipe
    Garcia-Ruiz, Eli
    Perez y Lopez, Nuria
    Juarez-Valdes, Eumir, I
    Lopez-Luria, Adriana
    Maria Remes-Troche, Jose
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (17) : 2119 - 2126
  • [38] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [39] Model for end-stage liver disease - Did the new liver allocation policy affect waiting list mortality?
    Austin, Mary T.
    Poulose, Benjamin K.
    Ray, Wayne A.
    Arbogast, Patrick G.
    Feurer, Irene D.
    Pinson, Wright
    ARCHIVES OF SURGERY, 2007, 142 (11) : 1079 - 1085
  • [40] Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
    Carrion, Andres F.
    Khaderi, Saira A.
    Sussman, Norman L.
    LIVER TRANSPLANTATION, 2016, 22 (03) : 279 - 280